The challenges of introducing routine G6PD testing into radical cure: a workshop report
The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative and a quantitative...
Main Authors: | Ley, B, Luter, N, Espino, F, Devine, A, Kalnoky, M, Lubell, Y, Thriemer, K, Baird, J, Poirot, E, Conan, N, Kheong, C, Dysoley, L, Khan, W, Dion-Berboso, A, Bancone, G, Hwang, J, Kumar, R, Price, R, von Seidlein, L, Domingo, G |
---|---|
Format: | Journal article |
Published: |
BioMed Central
2015
|
Similar Items
-
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
by: Kamala Thriemer, et al.
Published: (2021-04-01) -
Methods for the field evaluation of quantitative G6PD diagnostics: a review
by: Ley, B, et al.
Published: (2017) -
Methods for the field evaluation of quantitative G6PD diagnostics: a review
by: Benedikt Ley, et al.
Published: (2017-09-01) -
A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
by: Sadhewa, A, et al.
Published: (2023) -
A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
by: Arkasha Sadhewa, et al.
Published: (2023-04-01)